Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Orthopedic Oncology received 61 citations as per Google Scholar report
Liquid biopsy is a minimally invasive diagnostic technique that detects cancer-related genetic material, such as circulating tumor DNA (ctDNA) or RNA, in bodily fluids like blood. It is used to monitor tumor progression and response to treatment in orthopedic oncology.
Liquid biopsy in orthopedic oncology involves analyzing blood or other fluids to identify biomarkers associated with bone tumors. This technique offers a non-invasive alternative to traditional tissue biopsies, allowing for real-time monitoring of tumor dynamics, assessment of treatment efficacy, and early detection of relapse. Liquid biopsy provides valuable insights into the molecular landscape of bone sarcomas, aiding in personalized treatment planning and improving patient management.